CN Patent
CN102905707A — 含有苯基丙氨酸衍生物的医药制剂
Assigned to EA Pharma Co Ltd · Expires 2013-01-30 · 13y expired
What this patent protects
本发明提供一种医药制剂,其含有:分散于水溶性高分子物质基质中的由式(A)表示的特定的苯基丙氨酸衍生物或其医药上容许的盐,和交聚维酮。关于该医药制剂,即使增加该苯基丙氨酸衍生物或其医药上容许的盐在一次的给药单位中的含量,溶解性和保存稳定性也优良。 (A)
USPTO Abstract
本发明提供一种医药制剂,其含有:分散于水溶性高分子物质基质中的由式(A)表示的特定的苯基丙氨酸衍生物或其医药上容许的盐,和交聚维酮。关于该医药制剂,即使增加该苯基丙氨酸衍生物或其医药上容许的盐在一次的给药单位中的含量,溶解性和保存稳定性也优良。 (A)
Drugs covered by this patent
- Lytgobi (futibatinib) · Taiho Oncology
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.